Clinical Trial Update: Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial of atomoxetine hydrochloride in adults with ADHD and comorbid social anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Social Anxiety Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Comorbid Social Anxiety Disorder | Phase 4 | Status: COMPLETED